Space, the final frontier for…med ed?

Share this article:
A healthcare media company working with XM Satellite Radio has launched a 24/7 channel aimed at helping healthcare providers stay current with medical advances. ReachMD’s short-form programming, beamed via satellite signal XM 233, was launched at the American College of Cardiology’s annual meeting in New Orleans last March.

“All the stars are aligned,” joked Mike Seinfeld, ReachMD chief executive.

Programming, hosted by MD- and PhD-level clinicians/researchers, includes clinicians’ roundtable discussion, breaking medical news and special shows. ReachMD plans to offer CME credits via a voice-activated cell phone system starting next month, Seinfeld told MM&M.

Satellite broadcasting is the latest frontier among a burgeoning array of platforms for educating physicians.

ReachMD says it fills a new niche. “[Physicians] needed a national platform to discuss clinical issues that they deal with every day,” said Sharon Griff, ReachMD VP of marketing.

A partnership allows  ReachMD to cull highlights from AMA publication AM News weekly. An editorial board of content advisors, medical producers and reviewers scours medical journals and other sources for topics. Current sponsors include Amgen.

ReachMD was started by obstetrician David Preskill, who didn’t have time to keep up with medical news. Griff cited another reason for the always-on physician news channel: the increasingly informed patient.

“It would be nice for physicians to be as up-to-date or more than the patients they are treating,” she said.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.